The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From a Latin American Inflammatory Bowel Disease Program.


Journal

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
ISSN: 1538-9766
Titre abrégé: Gastroenterol Nurs
Pays: United States
ID NLM: 8915377

Informations de publication

Date de publication:
Historique:
entrez: 29 1 2020
pubmed: 29 1 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Inflammatory bowel disease requires long-term treatment to maintain disease control. Favorable follow-up of patients indicates attention from a multidisciplinary team, in which the nurse's responsibilities have great importance. The aim of this observational, descriptive study was to describe the role of an inflammatory bowel disease nurse in the management of patients in a tertiary center in Chile, including all patients in follow-up between January 2016 and April 2017. Inflammatory bowel disease nurse contacts were recorded and classified. Demographic data, clinical variables, and patient satisfaction were also analyzed. A total of 597 patients (51%) were in follow-up over the 16-month period; 63% had ulcerative colitis, with a median age of 35 years. The inflammatory bowel disease nurse performed 760 contacts in 253 patients (42% of the follow-up patients). The most frequent nurse interventions were reinforcement of medical indications (42%), assessment of laboratory results (17%), and disease follow-up (12%); 49% related to education. Nurse interventions were focused in more severely ill patients; flares during the follow-up, biological therapy, immunomodulators, and steroids were all statistically significant. Of a sample of 107 patients surveyed, 96% perceived the inflammatory bowel disease program as excellent/good. The inflammatory bowel disease nurse plays an important role in the follow-up and management, specifically in education, of more severely ill patients.

Identifiants

pubmed: 31990879
doi: 10.1097/SGA.0000000000000436
pii: 00001610-202001000-00015
doi:

Types de publication

Journal Article

Langues

eng

Pagination

E16-E23

Références

Abraham C., Ruhimovich N., Benjaminov F., Konikoff F. M., Naftali T. (2017). N821. Communication with IBD nurse is associated with disease severity but not with better adherence to treatment. Journal of Crohn's and Colitis, 11(Suppl. 1), S500. doi:10.1093/ecco-jcc/jjx002.945
Amo L., González-Lama Y., Suárez C., Blázquez I., Matallana V., Calvo M., Abreu L. (2016). Impact of the incorporation of a nurse in an inflammatory bowel disease unit. Gastroenterología y Hepatología, 39(5), 318–323. doi:10.1016/j.gastrohep.2015.09.004
Anderson G., Marsden E. (2012). Audit of an inflammatory bowel disease (IBD) telephone helpline set up and managed by IBD specialist nurses. Gastrointestinal Nursing, 10(5), 24–30. doi:10.12968/gasn.2012.10.5.24
Bager P., Chauhan U., Greveson K., Jäghult S., Moortgat L., Kemp K. (2018). Systematic review: Advice lines for patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 53(5), 506–512. Advance online publication: doi:10.1080/00365521.2017.1401116.
Belling R., McLaren S., Woods L. (2009). Specialist nursing interventions for inflammatory bowel disease. The Cochrane Database of Systematic Reviews, (4), CD006597. doi:10.1002/14651858.CD006597.pub2
Coenen S., Weyts E., Vermeire S., Ferrante M., Noman M., Ballet V., Van Assche G. (2017). Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care. European Journal of Gastroenterology & Hepatology, 29(6), 646–650. doi:10.1097/MEG.0000000000000839
Conley S., Redeker N. (2016). A systematic review of self-management interventions for inflammatory bowel disease. Journal of Nursing Scholarship, 48(2), 118–127. doi:10.1111/jnu.12189
Dignass A., Lindsay J. O., Sturm A., Windsor A., Colombel J. F., Allez M., Van Assche G. (2012). Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: Current management. Journal of Crohn's and Colitis, 6(10), 991–1030. doi:10.1016/j.crohns.2012.09.002
Glatter J., Sephton M., Garrick V. (2013). The revised inflammatory bowel disease (IBD) standards and the IBD nurse role. Gastrointestinal Nursing, 11(10), 28–34. doi:10.12968/gasn.2013.11.10.28
Golik M., Kurek M., Poteralska A., Bieniek E., Marynka A., Pabich G., Rydzewska G. (2014). Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in Poland. Przegla d Gastroenterologiczny, 9(4), 179–193. doi:10.5114/pg.2014.45098
Greveson K., Woodward S. (2013). Exploring the role of the inflammatory bowel disease nurse specialist. British Journal of Nursing, 22(16), 952–954, 956–958.
Guarini A., Marinis F., Kohn A., Orzes N., D'Incà R., Iannone T., Zullo A; Italian IBD Nurses Study Group. (2016). Inflammatory bowel disease nurse specialists for patients on biological therapies: A nationwide Italian survey. Annals of Gastroenterology, 29(4), 492–496.
Hernández-Sampelayo P., Seoane M., Oltra L., Marín L., Torrejón A., Vera M. I., Casellas F. (2010). Contribution of nurses to the quality of care in management of inflammatory bowel disease: A synthesis of the evidence. Journal of Crohn's and Colitis, 4(6), 611–622. doi:10.1016/j.crohns.2010.08.009
Hibi T., Panaccione R., Katafuchi M., Yokoyama K., Watanabe K., Matsui T., Suzuki Y. (2017). The 5C concept and 5s principles in inflammatory bowel disease management. Journal of Crohn's and Colitis, 11(11), 1302–1308. doi:10.1093/ecco-jcc/jjx085
Holbrook K. (2007). A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease. Journal of Clinical Nursing, 16(8), 1427–1434.
Husain A., Triadafilopoulos G. (2004). Communicating with patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 10(4), 444–450; discussion 451.
Johns K. (2017). N810. Audit of patient satisfaction with telephone reviews for inflammatory bowel disease. Journal of Crohn's and Colitis, 11(Suppl. 1), S496. doi:10.1093/ecco-jcc/jjx002.934
Kawakami A., Waga M., Tyrrell T., Yarrow H., O'Connor M. (2016). N013. A patient satisfaction survey of the telephone advice-line service for the management of inflammatory bowel disease. Journal of Crohn's and Colitis, 10(Suppl. 1), S500. doi:10.1093/ecco-jcc/jjw019.890
Kemp K., Dibley L., Chauhan U., Greveson K., Jäghult S., Ashton K., Bager P. (2018). 2nd N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis. Journal of Crohn's and Colitis, 12(7), 760–776. Advance online publication: doi:10.1093/ecco-jcc/jjy020
Knowles S. R., Graff L. A., Wilding H., Hewitt C., Keefer L., Mikocka-Walus A. (2018). Quality of life in inflammatory bowel disease: A systematic review and meta-analyses-part I. Inflammatory Bowel Diseases, 24(4), 742–751. doi:10.1093/ibd/izx100
Leach P., De Silva M., Mountifield R., Edwards S., Chitti L., Fraser R. J., Bampton P. (2014). The effect of an inflammatory bowel disease nurse position on service delivery. Journal of Crohn's and Colitis, 8(5), 370–374. doi:10.1016/j.crohns.2013.09.018
Louis E., Dotan I., Ghosh S., Mlynarsky L., Reenaers C., Schreiber S. (2015). Optimising the inflammatory bowel disease unit to improve quality of care: Expert recommendations. Journal of Crohn's and Colitis, 9(8), 685–691. doi:10.1093/ecco-jcc/jjv085
Mawdsley J. E., Irving P. M., Makins R. J., Rampton D. S. (2006). Optimizing quality of outpatient care for patients with inflammatory bowel disease: The importance of specialist clinics. European Journal of Gastroenterology & Hepatology, 18(3), 249–253.
Mikocka-Walus A., Andrews J. M., Rampton D., Goodhand J., van der Woude J., Bernstein C. N. (2014). How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. Journal of Crohn's and Colitis, 8(12), 1668–1674. doi:10.1016/j.crohns.2014.07.009
Mocciaro F., Pecoraro G. M., Di Mitri R., Scimeca D., Bossa F., Russo G., Tinè F. (2017). Nurse in patients' health status assessment: Data from a pilot study assessing agreement among nurse and gastroenterologist in computing IBD-clinical scores. Digestive and Liver Disease, 49(10), 1110–1114. doi:10.1016/j.dld.2017.06.009
Molodecky N. A., Soon I. S., Rabi D. M., Ghali W. A., Ferris M., Chernoff G., Kaplan G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46–54. e42; quiz e30. doi:10.1053/j.gastro.2011.10.001
Morar P. S., Sevdalis N., Warusavitarne J., Hart A., Green J., Edwards C., Faiz O. (2017). Establishing the aims, format and function for multidisciplinary team-driven care within an inflammatory bowel disease service: A multicentre qualitative specialist-based consensus study. Frontline Gastroenterology, 9(1), 29–36. doi:10.1136/flgastro-2017-100835
Mowat C., Cole A., Windsor A., Ahmad T., Arnott I., Driscoll R., Bloom S; IBD Section of the British Society of Gastroenterology. (2011). Guidelines for the management of inflammatory bowel disease in adults. Gut, 60(5), 571–607. doi:10.1136/gut.2010.224154
Panés J., O'Connor M., Peyrin-Biroulet L., Irving P., Petersson J., Colombel J. F. (2014). Improving quality of care in inflammatory bowel disease: What changes can be made today? Journal of Crohn's and Colitis, 8(9), 919–926. doi:10.1016/j.crohns.2014.02.022
Plevinsky J. M., Greenley R. N., Fishman L. N. (2016). Self-management in patients with inflammatory bowel disease: Strategies, outcomes, and integration into clinical care. Clinical and Experimental Gastroenterology, 9, 259–267. doi:10.2147/CEG.S106302
Read A. M., Mayberry J. F. (2000). Doctor or nurse? The patients' choice. Postgraduate Medical Journal, 76(894), 212–214.
Reid L. W., Chivers S., Plummer V., Gibson P. (2010). Inflammatory bowel disease management: A review of nurses' roles in Australia and the United Kingdom. Australian Journal of Advanced Nursing, 27(2), 19–26.
Ruiz N., Camargo R., Alcain G., Recio D., Carreño R. (2016). N022. Phone assistance by nursing consultation in an inflammatory bowel disease unit: The ability to solve problems. Journal of Crohn's and Colitis, 10(Suppl. 1), S504. doi:10.1093/ecco-jcc/jjw019.899
Schoultz M., Macaden L., Watson A. J. (2016). Co-designing inflammatory bowel disease (IBD) services in Scotland: Findings from a nationwide survey. BMC Health Services Research, 16, 231. doi:10.1186/s12913-016-1490-7
Simian D., Flores L., Quera R., Kronberg U., Ibáñez P., Figueroa C., Lubascher J. (2017). Assessment of disease-related knowledge and possible factors associated with the knowledge level among Chilean patients with inflammatory bowel disease. Journal of Clinical Nursing, 26(11–12), 1508–1515. doi:10.1111/jocn.13436
Simian D., Fluxá D., Flores L., Lubascher J., Ibáñez P., Figueroa C., Quera R. (2016). Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World Journal Gastroenterology, 22(22), 5267–5275. doi:10.3748/wjg.v22.i22.5267
Simian D., Quera R. (2016). Towards an integral management of inflammatory bowel disease. Revista Médica de Chile, 144(4), 488–495. doi:10.4067/S0034-98872016000400010
Squires S. I., Boal A. J., Lamont S., Naismith G. D. (2017). Implementing a self-management strategy in inflammatory bowel disease (IBD): Patient perceptions, clinical outcomes and the impact on service. Frontline Gastroenterology, 8(4), 272–278. doi:10.1136/flgastro-2017-100807
Squires S. I., Boal A. J., Naismith G. D. (2016). The financial impact of a nurse-led telemedicine service for inflammatory bowel disease in a large district general hospital. Frontline Gastroenterology, 7(3), 216–221. doi:10.1136/flgastro-2015-100630
Torres J., Mehandru S., Colombel J. F., Peyrin-Biroulet L. (2017). Crohn's disease. Lancet, 389(10080), 1741–1755. doi:10.1016/S0140-6736(16)31711-1
Ungaro R., Mehandru S., Allen P. B., Peyrin-Biroulet L., Colombel J. F. (2017). Ulcerative colitis. Lancet, 389(10080), 1756–1770. doi:10.1016/S0140-6736(16)32126-2
Walsh A. J., Bryant R. V., Travis S. P. (2016). Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology & Hepatology, 13(10), 567–579. doi:10.1038/nrgastro.2016.128

Auteurs

Daniela Simian (D)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Lilian Flores (L)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Rodrigo Quera (R)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Patricio Ibáñez (P)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Carolina Figueroa (C)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Jaime Lubascher (J)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Gonzalo Pizarro (G)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Udo Kronberg (U)

Daniela Simian, RN, Academic Research Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Lilian Flores, RN, is Nurse Coordinator Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Rodrigo Quera, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Patricio Ibáñez, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Carolina Figueroa, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Jaime Lubascher, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Gonzalo Pizarro, MD, Gastroenterology Service, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.
Udo Kronberg, MD, Colorectal Surgery Unit, Inflammatory Bowel Disease Program, Clínica Las Condes, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH